“The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...
Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide and ...
T: The New York Times Style Magazine MENA is celebrating its regional launch in a big way with the launch of Craft & Code.
ITP leads to abnormal bruising and bleeding thanks to low platelet levels—a type of blood cell that helps with clotting. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results